Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid

by Wang Zhonghua, Wang Biyun, Zhang Jian, Sun Si, Jia Zhen, Zhang Qunling, Xu Xiaofeng, Zhao Xinmin, Hu Xichun
Published 2011-09-01

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

by Qian Jun, Li Chuan, Wang Fengqing, Yv Ke, Jia Ka, Lv Fangfang, Guo Haiyi, Chen Lei, Zhao Xinmin, Li Jin, Zheng Chunlei, Zuo Yunxia
Published 2010-10-01